Horizon Therapeutics Public Limited Co (fka HZNP)

[Investor100]

Hedge Funds-News
Deerfield Management’s Top Health Stocks ~ Auspex Pharmaceuticals Inc (ASPX), Horizon Pharma PLC (HZNP), AbbVie Inc (ABBV)

Read more at http://www.insidermonkey.com/blog/deerfield-managements-top-health-stocks-auspex-pharmaceuticals-inc-aspx-horizon-pharma-plc-hznp-abbvie-inc-abbv-350499/#ROKhb1QppOrzXKMM.99

Deerfield Management’s second-largest health investment was in Horizon Pharma PLC (NASDAQ:HZNP), in which it owns 12.79 million shares valued at $332.23 million. The specialty biopharmaceutical company has a market cap of $5.02 billion and its shares currently trade at $32.28. Horizon Pharma completed the acquisition of Horizon Therapeutics Inc (NASDAQ:HPTX) on May 7 with a tender offer for 86% of the outstanding shares of the latter. With this acquisition, Horizon Pharma PLC (NASDAQ:HZNP) added two successful medicines for the treatment of urea cycle disorders, RAVICTI and BUPHENYL, to its portfolio. The biopharmaceutical company reported net sales of $113.1 million during the first quarter of 2015 with a net loss of $19.6 million. Broadfin Capital and Healthcor Management LP are two other health-focused investment firms that hold major positions in Horizon Pharma PLC (NASDAQ:HZNP), which has gained an even-more-impressive 152% year-to-date.
Read more at http://www.insidermonkey.com/blog/deerfield-managements-top-health-stocks-auspex-pharmaceuticals-inc-aspx-horizon-pharma-plc-hznp-abbvie-inc-abbv-350499/#ROKhb1QppOrzXKMM.99

http://www.insidermonkey.com/blog/deerfield-managements-top-health-stocks-auspex-pharmaceuticals-inc-aspx-horizon-pharma-plc-hznp-abbvie-inc-abbv-350499/


Investor 100